ALS Therapy Development Institute Signs Manufacturing Agreement with Microbix
18-Oct-2007 -
Microbix Biosystems Inc. announced that it has been selected by the ALS Therapy Development Institute (ALS TDI) in the U.S. to manufacture a series of adenoviruses that will be used in research aimed at fighting the disease Amyotrophic Lateral Sclerosis (ALS), often called Lou Gehrig's ...
amyotrophic lateral sclerosis
animal experiments
genes
+4